The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 03, 2019

Filed:

Oct. 25, 2016
Applicant:

Medimmune Limited, Cambridge, GB;

Inventors:

Christophe Queva, Bainbridge Island, WA (US);

Michelle Morrow, Cambridge, GB;

Scott Hammond, Olney, MD (US);

Marat Alimzhanov, Wellesley, MA (US);

John Babcock, Burnaby, CA;

Ian Nevin Foltz, Burnaby, CA;

Jaspal Singh Kang, Surrey, CA;

Laura Sekirov, Burnaby, CA;

Melanie Boyle, Cambridge, GB;

Matthieu Chodorge, Cambridge, GB;

Ross A. Stewart, Cambridge, GB;

Kathleen Ann Mulgrew, Gaithersburg, MD (US);

Assignee:

MEDIMMUNE LIMITED, Cambridge, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/70 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

Human monoclonal antibodies directed against B7-H1 and uses of these antibodies in diagnostics and for the treatment of diseases associated with the activity and/or expression of B7-H1 are disclosed. Additionally, hybridomas or other cell lines expressing such antibodies are disclosed.


Find Patent Forward Citations

Loading…